Skip to main content
Displaying 11 - 20 of 4049
# Title Department Research Year
11 From Design to Activity: Linker Flexibility in 3-Spiro-2-Oxindoline VEGFR-2 Inhibitors Department of Medicinal Chemistry 2026
12 Impact of sulfamethoxazole, trimethoprim, diclofenac, carbamazepine, and their mixture on the metabolism of Lemna minor: a targeted metabonomic study Department of Pharmacognosy 2026
13 Integrated omics reveal a unique antibacterial mechanism of action for the small molecule HSI#6 Department of Microbiology and Immunology 2026
14 Ligand-based design and synthesis of novel 3-spiro-2-oxindoline derivatives as potent VEGFR-2 inhibitors with antiproliferative activity and cell cycle arrest Department of Medicinal Chemistry 2026
15 Nature-inspired chalcone-functionalized paracetamol derivatives as potential anticancer leads: synthesis, biological evaluation, apoptotic mechanisms, and in silico docking studies Department of Pharmaceutical Organic Chemistry 2026
16 Phytochemical and antidiabetic evaluation of Bauhinia tomentosa L. aerial parts Department of Pharmacognosy 2026
17 Rational design of 2-substituted thio-7-chloroquinazolin-4(3H)-one derivatives as dual EGFR/VEGFR-2 inhibitors with broad-Spectrum anticancer and apoptotic activities Department of Medicinal Chemistry 2026
18 Terbium-enhanced poly(Pyrosin) sensor for the concurrent electroanalysis of L-Dopa, Carbidopa, and Istradefylline in human plasma Department of Pharmaceutical Analytical Chemistry 2026
19 Unlocking anti-scabies potential of amaryllidaceae alkaloids through integrated network pharmacology and experimental validation Department of Pharmacognosy 2026
20 Unveiling the anticancer activity of Fujairah honey via bioactivity-guided fractionation and metabolomics Department of Pharmacognosy 2026